Transcranial Magnetic Stimulation (TMS) Treatment for Post-Traumatic Stress

Recruiting
18 years - 60 years
All
Phase
1
40 participants needed
1 Location
Brief description of study
Evaluates novel Transcranial Magnetic Stimulation (TMS)
methods for the treatment of post-traumatic stress disorder (PTSD) and
depressive symptoms to determine which strategies provide the greatest benefit to patients.
Transcranial Magnetic Stimulation (TMS) is a non-invasive
brain stimulation technique FDA-approved for the treatment of major depressive
disorder (MDD) and obsessive compulsive disorder (OCD). However, there is
growing evidence that a targeted strategy for delivering TMS treatment would
yield superior clinical outcomes if it were more tailored to individual
neuroanatomy. In this study, we plan to examine whether functional Magnetic Resonance Imaging (fMRI) guided TMS might yield an even greater leap forward in promoting optimal
clinical outcomes.
Detailed description of study
The study provides TMS treatment at no cost to participants; no insurance is required. Participation includes 20 sessions of TMS treatment over the
course of 7 weeks, clinical interviews with study staff, one fMRI scan, and monthly follow-up phone calls for 6 months post-treatment.
Compensation for the fMRI visit is provided.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Depression,Post-Traumatic Stress,PTSD,Major Depressive Disorder,MDD,Trauma,Survivor,Veteran,Flashbacks
-
Age: 18 years - 60 years
-
Gender: All
- Experiencing symptoms of PTSD and depression
- Currently not taking any psychiatric medication
- Seeking a treatment option
Updated on
19 Feb 2024.
Study ID: 826007